Abstract
A man in his early seventies underwent low anterior resection and partial resection of the liver for the rectal cancer and liver metastasis. However, 4 months after the surgery, he was found to have a liver tumor at S5 and S7 by abdominal CT scan. Then, he underwent chemotherapy (mFOLFOX6), but the metastatic tumor was progressive. We selected FOLFIRI + cetuximab regimen for second-line therapy to resect the metastatic tumor. As the metastatic lesion was become smaller after 4-course of the regimen including cetuximab, we decided to perform a radical resection. We conducted a right lobectomy of the liver, and the tumor was completely resected.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology
-
Adenocarcinoma / therapy*
-
Aged
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Cetuximab
-
Colonic Neoplasms / pathology*
-
Combined Modality Therapy
-
Fluorouracil / administration & dosage
-
Hepatectomy*
-
Humans
-
Leucovorin / administration & dosage
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / therapy*
-
Male
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Cetuximab
-
Leucovorin
-
Fluorouracil
-
Camptothecin